AEON Biopharma is developing ABP-450, a botulinum toxin meant to be a biosimilar to Botox for therapeutic uses. It last closed at $0.12 on Nov 20, down 7.59% on the day. The next earnings report for AEON is expected around Mon, Mar 29, 2027, after the close. For the quarter ended Sep 2026, AEON reported EPS of $0.01. Over its last 8 reports the stock moved an average of 7.4% the session after earnings. Over the last 12 months AEON insiders bought $301K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is AEON in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AEON.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on AEONStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
AEON · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 56% below its 20 day and 89% below its 50 day average. It is 389% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 32), near oversold. The nearest support is the Pivot S1 at $0.12, and the nearest resistance the Pivot at $0.13.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 22.6%/day
Key levels
$1.4552 week high+1108.3%
$0.60200 day average+400.0%
$0.27100 day average+125.0%
$0.25Swing high (Oct 21)+108.3%
$0.2350 day average+91.7%
$0.1920 day average+58.3%
$0.13Pivot R1+8.3%
$0.13Pivot+8.3%
$0.12Pivot S1+0.0%
$0.12Last close
$0.1152 week low−8.3%
$0.11Swing low (Nov 17)−8.3%
Indicators
RSI (14)
31.51
Weak, oversold below 30
Neutral
MACD
-0.03
Below its signal line
Bearish
Stochastic
11.1
Near the bottom of its range
Oversold
ADX (14)
31.2
Trending down
Williams %R
-90.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-93.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−30.1%
Change over 10 sessions
Bearish
ATR (14)
$0.03
Typical daily range, 22.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, nearing oversold
Short trendBearish
Long trendNot enough history
MomentumFading
StretchNear oversold
VolatilityHigh, 110.9%/day
Key levels
$1.4552 week high+1108.3%
$0.60200 day average+400.0%
$0.27100 day average+125.0%
$0.25Swing high (Oct 21)+108.3%
$0.2350 day average+91.7%
$0.1920 day average+58.3%
$0.13Pivot R1+8.3%
$0.13Pivot+8.3%
$0.12Pivot S1+0.0%
$0.12Last close
$0.1152 week low−8.3%
$0.11Swing low (Nov 17)−8.3%
Indicators
RSI (14)
31.83
Weak, oversold below 30
Neutral
MACD
-0.19
Above its signal line
Bullish
Stochastic
10.3
Near the bottom of its range
Oversold
ADX (14)
21.6
Weak trend
Williams %R
-94.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-195.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−62.4%
Change over 10 sessions
Bearish
ATR (14)
$0.14
Typical daily range, 110.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for AEON
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AEON did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow AEON usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for AEONHow many large options trades hit AEON, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in AEON in the last 90 days.
From SEC Form 4 filings by AEON's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AEON is in one of them and how their past AEON trades turned out.
AEON Biopharma is a biopharmaceutical company based in Aliso Viejo, California. It is developing ABP-450, a botulinum toxin intended to serve as a biosimilar to Botox for therapeutic medical uses rather than cosmetic ones. The product is still in development, and the company is working toward a regulatory filing in the United States. Its intended customers are physicians and patients who use botulinum toxin treatments for medical conditions.